Steven Zelenkofske - Jan 23, 2025 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ Matthew K. Szot, Attorney-in-fact
Stock symbol
CVKD
Transactions as of
Jan 23, 2025
Transactions value $
$0
Form type
4
Date filed
1/24/2025, 06:12 PM
Previous filing
Jan 19, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock Options Award $0 +20K $0.00 20K Jan 23, 2025 Common Stock 20K $19.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2025.